AzurRx BioPharma (AZRX) Upsizes Previously Announced 5.5M Share Bought Deal offering to 9.1M Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
After-Hours Stock Movers 07/22: (SCKT) (SNAP) (TWTR) Higher; (SAM) (AZRK) Lower (more...)
July 22, 2021 5:51 PM EDTAfter-Hours Stock Movers
Socket Mobile (NASDAQ: SCKT) 88% HIGHER; reported Q2 EPS of $0.27, $0.24 better than the analyst estimate of $0.03. Revenue for the quarter came in at $6 million versus the consensus estimate of $4.07 million.
Boston Beer Co. (NYSE: SAM) 18.4% LOWER; reported Q2 EPS of $4.75, $2.10 worse than the analyst estimate of $6.85. Revenue for the quarter came in at $602.8 million versus the consensus estimate of $665.25 million.
AzurRx BioPharma (AZRX) Announces 5.5M Share Bought Deal Offering at $0.55/sh
July 22, 2021 4:52 PM EDTAzurRx BioPharma, Inc. (NASDAQ: AZRX) a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 5,454,546 shares of common stock of the Company, at a price to the public of $0.55 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about July 27, 2021, subject to satisfaction of customary closing... More
